These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16545908)

  • 1. Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
    Hall GC; Carroll D; Parry D; McQuay HJ
    Pain; 2006 May; 122(1-2):156-62. PubMed ID: 16545908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.
    Hall GC; Carroll D; McQuay HJ
    BMC Fam Pract; 2008 May; 9():26. PubMed ID: 18460194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population.
    Hall GC; Morant SV; Carroll D; Gabriel ZL; McQuay HJ
    BMC Fam Pract; 2013 Feb; 14():28. PubMed ID: 23442783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions.
    Sadosky A; McDermott AM; Brandenburg NA; Strauss M
    Pain Pract; 2008; 8(1):45-56. PubMed ID: 18211592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings.
    Gore M; Dukes E; Rowbotham DJ; Tai KS; Leslie D
    Eur J Pain; 2007 Aug; 11(6):652-64. PubMed ID: 17126045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K.
    Berger A; Sadosky A; Dukes E; Edelsberg J; Oster G
    Pain Pract; 2009; 9(1):18-34. PubMed ID: 19019054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence rates and treatment of neuropathic pain conditions in the general population.
    Dieleman JP; Kerklaan J; Huygen FJPM; Bouma PAD; Sturkenboom MCJM
    Pain; 2008 Jul; 137(3):681-688. PubMed ID: 18439759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin.
    Torrance N; Smith BH; Watson MC; Bennett MI
    Fam Pract; 2007 Oct; 24(5):481-5. PubMed ID: 17670804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All pain is not the same: an overview of neuropathic pain in the elderly.
    Martin CM; Saleeby LG
    Consult Pharm; 2007 Apr; 22(4):283-94. PubMed ID: 17658961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings.
    Navarro A; Saldaña MT; Pérez C; Torrades S; Rejas J
    Pain Med; 2010 May; 11(5):719-31. PubMed ID: 20345618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of trigeminal neuropathic pains.
    Zakrzewska JM
    Expert Opin Pharmacother; 2010 Jun; 11(8):1239-54. PubMed ID: 20426709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anticonvulsants drugs for neuropathic painful conditions.
    Hussain AM; Afshan G
    J Pak Med Assoc; 2008 Dec; 58(12):690-6. PubMed ID: 19157324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.
    Rayment C; Hjermstad MJ; Aass N; Kaasa S; Caraceni A; Strasser F; Heitzer E; Fainsinger R; Bennett MI;
    Palliat Med; 2013 Sep; 27(8):714-21. PubMed ID: 23175513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.
    Zelman DC; Gore M; Dukes E; Tai KS; Brandenburg N
    J Pain Symptom Manage; 2005 Apr; 29(4):401-10. PubMed ID: 15857744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localised neuropathic pain in the primary care setting: a cross-sectional study of prevalence, clinical characteristics, treatment patterns, quality of life and sleep performance.
    Mick G; Serpell M; Baron R; Mayoral V; Hans G; Mendez I; Artime E; Qizilbash N; Sohns M
    Curr Med Res Opin; 2021 Feb; 37(2):293-302. PubMed ID: 33140987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database.
    Asomaning K; Abramsky S; Liu Q; Zhou X; Sobel RE; Watt S
    Int J Clin Pract; 2016 May; 70(5):380-8. PubMed ID: 27028939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropathic pain in children].
    Fournier-Charrière E
    Arch Pediatr; 2010 Jun; 17(6):665-6. PubMed ID: 20654832
    [No Abstract]   [Full Text] [Related]  

  • 19. Complexity of pain management among patients with nociceptive or neuropathic neck, back, or osteoarthritis diagnoses.
    Kozma CM; Provenzano DA; Slaton TL; Patel AA; Benson CJ
    J Manag Care Spec Pharm; 2014 May; 20(5):455-66b. PubMed ID: 24761817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Toxin Treatment of Neuropathic Pain.
    Mittal SO; Safarpour D; Jabbari B
    Semin Neurol; 2016 Feb; 36(1):73-83. PubMed ID: 26866499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.